HAL

Halliburton is a high-quality oilfield-services franchise caught in a cyclical down-leg. FY2025 revenue slipped 3.3% to $22.2B — the second straight year of decline off the FY2023 $23.0B peak — but the real story is the bottom line: net income collapsed 48.7% to $1.28B and operating income fell 40.9% to $2.26B, crushing net margin to 5.8% and operating margin to 10.2%. The MD&A's table of contents flags 'Note 2. Impairments and Other Charges' prominently, consistent with a profit drop far steeper than the revenue decline — earnings quality this year is weighed down by charges, not just lower activity. The audit is a clean KPMG unqualified opinion with effective internal controls, so the deterioration is operational/cyclical, not a reporting concern.

What keeps this a hold rather than a sell is the balance sheet and cash generation. Equity is $10.5B against $14.5B liabilities (1.39x), long-term debt is flat at $7.16B with zero current maturities, and cash is $2.21B. Operating cash flow of $2.93B less $1.25B capex leaves roughly $1.7B of free cash flow — enough to fund the $579M dividend and $1.01B of buybacks (which shrank the share count 3.5%) without leaning on the balance sheet. ROE is still a respectable 12.3%, and retained earnings grew 4.9%. This is a company that can comfortably wait out a soft patch.